Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vericiguat for heart failure after acute myocardial infarction
ChiCTR2300077753Phase 4Completed
- Sponsor
- China-Japan Union Hospital of Jilin University
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of vericiguat in heart failure (HF) (2 arms), sponsored by China-Japan Union Hospital of Jilin University. Primary endpoint: Whether left ventricular ejection fraction increased by at least 10% from baseline. Started Jul 2023; status: completed.
02
Drugs
vericiguat
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on ChiCTR2300077753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300077753.